Condor Capital Management Abbott Laboratories Transaction History

Condor Capital Management

$1.09 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $38,220 - $44,251	395 Added 1.4%	28,565 $2.76 Million
Q2 2022 Aug 09, 2022	BUY	$102.07 - $123.37 $16,535 - $19,985	162 Added 0.58%	28,170 $3.06 Million
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $56,553 - $68,963	496 Added 1.8%	28,008 $3.32 Million
Q4 2021 Feb 09, 2022	SELL	$115.53 - $141.46 $4.48 Million - $5.48 Million	-38,752 Reduced 58.48%	27,512 $3.87 Million
Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $79,095 - $87,502	-678 Reduced 1.01%	66,264 $7.83 Million
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $6,241 - $7,347	59 Added 0.09%	66,942 $7.76 Million
Q1 2021 May 10, 2021	SELL	$108.84 - $128.23 $82,391 - $97,070	-757 Reduced 1.12%	66,883 $8.02 Million
Q4 2020 Jan 29, 2021	BUY	$105.0 - $114.42 $10,395 - $11,327	99 Added 0.15%	67,640 $7.41 Million
Q3 2020 Nov 09, 2020	SELL	$91.64 - $111.29 $60,115 - $73,006	-656 Reduced 0.96%	67,541 $7.35 Million
Q2 2020 Aug 07, 2020	SELL	$76.57 - $98.0 $1,837 - $2,352	-24 Reduced 0.04%	68,197 $6.24 Million
Q1 2020 May 07, 2020	BUY	$62.82 - $91.86 $278,857 - $407,766	4,439 Added 6.96%	68,221 $5.38 Million
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $189,209 - $210,634	-2,410 Reduced 3.64%	63,782 $5.54 Million
Q3 2019 Nov 06, 2019	SELL	$81.84 - $88.74 $193,142 - $209,426	-2,360 Reduced 3.44%	66,192 $5.54 Million
Q2 2019 Aug 05, 2019	SELL	$72.88 - $85.0 $10,932 - $12,750	-150 Reduced 0.22%	68,552 $5.77 Million
Q1 2019 May 01, 2019	SELL	$66.22 - $80.06 $29,666 - $35,866	-448 Reduced 0.65%	68,702 $5.49 Million
Q4 2018 Feb 08, 2019	SELL	$65.56 - $74.27 $458 - $519	-7 Reduced 0.01%	69,150 $5 Million
Q3 2018 Nov 01, 2018	BUY	$60.81 - $73.36 $8,209 - $9,903	135 Added 0.2%	69,157 $5.07 Million
Q2 2018 Aug 01, 2018	SELL	$57.57 - $63.54 $12,204 - $13,470	-212 Reduced 0.31%	69,022 $4.21 Million
Q1 2018 May 04, 2018	SELL	$56.27 - $63.62 $20,876 - $23,603	-371 Reduced 0.53%	69,234 $4.15 Million
Q4 2017 Feb 08, 2018	BUY	$53.68 - $57.47 $8,105 - $8,677	151 Added 0.22%	69,605 $3.97 Million
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $3.34 Million - $3.73 Million	69,454	69,454 $3.71 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.5 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.05 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.76 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.29 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Condor Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Condor Capital Management with notifications on news.

Account